» Articles » PMID: 21843301

Urine C-peptide Creatinine Ratio is an Alternative to Stimulated Serum C-peptide Measurement in Late-onset, Insulin-treated Diabetes

Overview
Journal Diabet Med
Specialty Endocrinology
Date 2011 Aug 17
PMID 21843301
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Serum C-peptide measurement can assist clinical management of diabetes, but practicalities of collection limit widespread use. Urine C-peptide creatinine ratio may be a non-invasive practical alternative. The stability of C-peptide in urine allows outpatient or community testing. We aimed to assess how urine C-peptide creatinine ratio compared with serum C-peptide measurement during a mixed-meal tolerance test in individuals with late-onset, insulin-treated diabetes.

Methods: We correlated the gold standard of a stimulated serum C-peptide in a mixed-meal tolerance test with fasting and stimulated (mixed-meal tolerance test, standard home meal and largest home meal) urine C-peptide creatinine ratio in 51 subjects with insulin-treated diabetes (diagnosis after age 30 years, median age 66 years, median age at diagnosis 54, 42 with Type 2 diabetes, estimated glomerular filtration rate > 60 ml min(-1) 1.73 m(-2) ).

Results: Ninety-minute mixed-meal tolerance test serum C-peptide is correlated with mixed-meal tolerance test-stimulated urine C-peptide creatinine ratio (r = 0.82), urine C-peptide creatinine ratio after a standard breakfast at home (r = 0.73) and urine C-peptide creatinine ratio after largest home meal (r = 0.71). A stimulated (largest home meal) urine C-peptide creatinine ratio cut-off of 0.3 nmol/mmol had a 100% sensitivity and 96% specificity (area under receiver operating characteristic curve = 0.99) in identifying subjects without clinically significant endogenous insulin secretion (mixed-meal tolerance test-stimulated C-peptide < 0.2 nmol/l). In detecting a proposed serum C-peptide threshold for insulin requirement (stimulated serum C-peptide < 0.6 nmol/l), a stimulated (largest home meal) urine C-peptide creatinine ratio cut-off of 0.6 nmol/mmol had a sensitivity and specificity of 92%.

Conclusion: In patients with insulin-treated diabetes diagnosed after age 30 years, urine C-peptide creatinine ratio is well correlated with serum C-peptide and may provide a practical alternative measure to detect insulin deficiency for use in routine clinical practice.

Citing Articles

Exploring the potential role of C-peptide in type 2 diabetes management.

Lin Y, McCrimmon R, Pearson E Diabet Med. 2025; 42(3):e15469.

PMID: 39797595 PMC: 11823364. DOI: 10.1111/dme.15469.


Quantifying beta cell function in the preclinical stages of type 1 diabetes.

Galderisi A, Carr A, Martino M, Taylor P, Senior P, Dayan C Diabetologia. 2023; 66(12):2189-2199.

PMID: 37712956 PMC: 10627950. DOI: 10.1007/s00125-023-06011-5.


Residual β-Cell Function Is Associated With Longer Time in Range in Individuals With Type 1 Diabetes.

Fuhri Snethlage C, McDonald T, Oram R, de Groen P, Rampanelli E, Schimmel A Diabetes Care. 2023; 47(7):1114-1121.

PMID: 37535870 PMC: 11208747. DOI: 10.2337/dc23-0776.


Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes.

Thomas N, Hill A, Dayan C, Oram R, McDonald T, Shields B Diabetes Care. 2023; 46(6):1156-1163.

PMID: 36802355 PMC: 7614569. DOI: 10.2337/dc22-2159.


Diagnostic Test Accuracy of Urine C-peptide Creatinine Ratio for the Correct Identification of the Type of Diabetes: A Systematic Review.

Pappachan J, Sunil B, Fernandez C, Lahart I, Ashraf A touchREV Endocrinol. 2022; 18(1):2-9.

PMID: 35949364 PMC: 9354948. DOI: 10.17925/EE.2022.18.1.2.